Supplementary Table 4 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial

MLA

Olivier Colomban, et al. Supplementary Table 4 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....49affbc4d6044d4a105a5583c24e7f31&authtype=sso&custid=ns315887.

APA

Olivier Colomban, Gilles Freyer, Eric Pujade-Lauraine, Alexandra Leary, Florence Joly, Annick Chevalier-Place, Pierre Combe, Isabelle Ray-Coquard, Gaëtan De Rauglaudre, Gwénael Ferron, Francesco Del Piano, Marianne Leheurteur, Philippe Follana, Jean-Emmanuel Kurtz, Nathalie Bonichon-Lamichhane, Christophe Desauw, Michel Fabbro, Sophie Abadie-Lacourtoisie, Jean-Pierre Lotz, … Benoit You. (2023). Supplementary Table 4 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.

Chicago

Olivier Colomban, Gilles Freyer, Eric Pujade-Lauraine, Alexandra Leary, Florence Joly, Annick Chevalier-Place, Pierre Combe, et al. 2023. “Supplementary Table 4 from CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....49affbc4d6044d4a105a5583c24e7f31&authtype=sso&custid=ns315887.